HOME >> MEDICINE >> NEWS
Early treatment of blinding eye disease in infants can prevent severe vision loss

An important clinical trial, sponsored by the National Eye Institute (NEI), a part of the National Institutes of Health (NIH), has provided doctors with improved prognostic indicators and treatment options for retinopathy of prematurity (ROP), a blinding disease that affects premature, low birthweight infants. ROP spurs the growth of abnormal blood vessels in the back of the eye. These vessels leak fluid and blood and scar the nerve tissue inside the eye, increasing the risk of retinal detachment and severe vision loss in infants.

Because it follows an unpredictable course, ROP presents doctors with difficult treatment decisions. In many infants the disease spontaneously regresses and spares vision. However, in some infants ROP progresses, resulting in serious visual impairment. Although current therapy can stem its progression, many infants are still blinded by the disease. Due to a lack of clinical criteria to predict which patients will ultimately develop severe vision loss from ROP, ophthalmologists were forced previously to defer treatment until it was clearly indicated. Unfortunately, as it turns out, delaying therapy can leave infants who might benefit more from early treatment with poor visual outcomes.

The Early Treatment for Retinopathy of Prematurity (ETROP) study results, published in the December issue of the Archives of Ophthalmology, demonstrated that premature infants, who are at the highest risk for developing vision loss from ROP, will retain better vision when therapy is administered in the early stage of the disease. This treatment approach was found to be better than waiting until ROP has reached the traditional treatment threshold. Just as importantly, the study also established the value of an improved risk assessment model to more accurately identify those infants who are at the highest risk for developing severe vision loss from ROP.

"Premature, low birthweight infants face a host of medical comp
'"/>

Contact: Ruth Poole
ruth@ski.org
415-345-2000
Smith-Kettlewell Eye Research Institute
31-Dec-2000


Page: 1 2 3 4

Related medicine news :

1. Early onset of puberty the EU gets serious
2. Early HIV screening prolongs life and is affordable, Stanford study shows
3. Early supported discharge services can reduce long term dependency for stroke patients
4. Early surgical treatment not always necessary for patients with brain haemorrhage
5. Early seizures after epilepsy surgery predict more seizures
6. Early learning leaves lasting changes in brain, Stanford owl study shows
7. Early detection reduces threat of foot injury in college basketball players
8. Early results shed light on lung cancer screening advance
9. Early disclosure: Post-operative radiotherapy improves progression-free survival in prostate cancer
10. Early reports of thrombosis after insertion of drug-eluting stents
11. Early behavior problems linked with wheezing later in childhood

Post Your Comments:
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, ... announced the two leaders who will deliver keynote presentations at the upcoming Digital ... Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based in Beverly Hills, Luxury ... truly superb luxury vehicles based on which of the latest and greatest vehicles their ... step forward in pursuit of this goal: a 2015 Rolls Royce Wraith rental ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Western ... and Mildred Goldstein Charitable Trust to establish the Abraham and Mildred Goldstein Endowment ... months after WCHN recruited nationally known gynecologic oncologist Thomas J. Rutherford, MD, PhD ...
(Date:9/2/2015)... ... 2015 , ... Date and time: Oct. 3, 2015, 9 a.m. to 4 ... Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The ... best-selling author Sam Keen based on his new book which he co-authored with his ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... safety and efficacy endpoint data collection, cloud analytics and workflow solutions today ... The series enables pharmaceutical researchers to participate in interactive programs in which ...
Breaking Medicine News(10 mins):Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3
(Date:9/2/2015)... , Sept. 2, 2015   About ELISA test ... common laboratory technologies that is used for measuring the ... solution. ELISA test uses various types of enzymes such ... the result is detected by photometry or fluorometry. ELISA ... of various infectious diseases such as HIV, pernicious anemia, ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ... Affairs in China (Basel, Switzerland - November 26-27, 2015)" ... provide a detailed overview of the key areas of pharmaceutical ... Hong Kong , Macau and ... - All important aspects of gaining and maintaining a ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP is ... trial will commence October 13, 2015. ... 510K fast-track approval program, Zimmer NexGen knee implant surpassed ... requires that companies provide evidence that the product is ... order to gain permissions. In 2001, ...
Breaking Medicine Technology:Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
Cached News: